Translational Biomarker Discovery in Clinical Metabolomics: An Introductory Tutorial
News Apr 08, 2013
Metabolomics is increasingly being applied towards the identification of biomarkers for disease diagnosis, prognosis and risk prediction. Unfortunately among the many published metabolomic studies focusing on biomarker discovery, there is very little consistency and relatively little rigor in how researchers select, assess or report their candidate biomarkers. In particular, few studies report any measure of sensitivity, specificity, or provide receiver operator characteristic (ROC) curves with associated confidence intervals. Even fewer studies explicitly describe or release the biomarker model used to generate their ROC curves. This is surprising given that for biomarker studies in most other biomedical fields, ROC curve analysis is generally considered the standard method for performance assessment. Because the ultimate goal of biomarker discovery is the translation of those biomarkers to clinical practice, it is clear that the metabolomics community needs to start "speaking the same language" in terms of biomarker analysis and reporting-especially if it wants to see metabolite markers being routinely used in the clinic. In this tutorial, we will first introduce the concept of ROC curves and describe their use in single biomarker analysis for clinical chemistry. This includes the construction of ROC curves, understanding the meaning of area under ROC curves (AUC) and partial AUC, as well as the calculation of confidence intervals. The second part of the tutorial focuses on biomarker analyses within the context of metabolomics. This section describes different statistical and machine learning strategies that can be used to create multi-metabolite biomarker models and explains how these models can be assessed using ROC curves. In the third part of the tutorial we discuss common issues and potential pitfalls associated with different analysis methods and provide readers with a list of nine recommendations for biomarker analysis and reporting. To help readers test, visualize and explore the concepts presented in this tutorial, we also introduce a web-based tool called ROCCET (ROC Curve Explorer & Tester, http://www.roccet.ca). ROCCET was originally developed as a teaching aid but it can also serve as a training and testing resource to assist metabolomics researchers build biomarker models and conduct a range of common ROC curve analyses for biomarker studies.
The article is published online in the journal Metabolomics and is free to access.
The Microbiological Art of Making a Better SausageNews
Fermented sausages can vary in taste quality depending on whether the fermentations begin “spontaneously”, or using a commercial starter culture. Scientists found that commercial starter culture produced sausages with higher acidity, and inferior taste, as compared with spontaneous fermentation. Using Next Generation Sequencing techniques, the investigators identified the relevant microbes and mapped the metabolic pathways, and used gas chromatography with mass spectrometry (GC-MS), to determine and quantify the metabolites produced during fermentation.READ MORE
Public Resource of Cellular Effects of Drugs and Genes Boosts Drug Discovery and Offers Insights Into Protein FunctionNews
Researchers have taken the Connectivity Map — a widely used resource of tools and data — to new heights with a massively scaled-up version including more cell types, more perturbations, and more types of data, including proteomic and cellular imaging data. For this new platform, the researchers have also improved its accessibility for the scientific community, enabling studies of small molecule and gene function and informing clinical trials.READ MORE
Integrative Prediction Model Uses “Omics”, Histopathology to Improve Cancer PrognosisNews
Scientists have shown that integrating histopathology, clinical history and omics data could allow clinicians to better formulate cancer treatment plans based on a patient’s predicted survival.READ MORE